Concepedia

Publication | Closed Access

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

88

Citations

30

References

2012

Year

Abstract

Tenofovir with either boosted protease inhibitor leads to a greater initial decline in eGFR than tenofovir with efavirenz; this decline may be worse with ATV/r than with LPV/r.

References

YearCitations

2009

25K

1976

15.3K

2006

5.7K

2000

5.4K

1998

5.2K

2008

2.6K

2000

1.7K

2010

403

2009

351

2002

343

Page 1